Cellectis SA
PAR:ALCLS

Watchlist Manager
Cellectis SA Logo
Cellectis SA
PAR:ALCLS
Watchlist
Price: 1.288 EUR -1.68%
Market Cap: 92.9m EUR

Wall Street
Price Targets

ALCLS Price Targets Summary
Cellectis SA

Wall Street analysts forecast ALCLS stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for ALCLS is 6.63 EUR with a low forecast of 6.565 EUR and a high forecast of 6.825 EUR.

Lowest
Price Target
6.565 EUR
410% Upside
Average
Price Target
6.63 EUR
415% Upside
Highest
Price Target
6.825 EUR
430% Upside
Cellectis SA Competitors:
Price Targets
4584
Kidswell Bio Corporation
87% Upside
XGN
Exagen Inc
12% Upside
NBIX
Neurocrine Biosciences Inc
28% Upside
SWTX
SpringWorks Therapeutics Inc
14% Upside
ORKA
Oruka Therapeutics Inc
225% Upside
RAPT
Rapt Therapeutics Inc
227% Upside
688687
Beijing Kawin Technology Share-holding Co Ltd
64% Upside
IVACC
Intervacc AB
549% Upside

Revenue
Forecast

Revenue Estimate
Cellectis SA

For the last 8 years the compound annual growth rate for Cellectis SA's revenue is -2%. The projected CAGR for the next 3 years is 9%.

-2%
Past Growth
9%
Estimated Growth
Estimates Accuracy
-27%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Cellectis SA

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-9%
Average Miss

Net Income
Forecast

Net Income Estimate
Cellectis SA

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-59%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is ALCLS's stock price target?
Price Target
6.63 EUR

According to Wall Street analysts, the average 1-year price target for ALCLS is 6.63 EUR with a low forecast of 6.565 EUR and a high forecast of 6.825 EUR.

What is Cellectis SA's Revenue forecast?
Projected CAGR
9%

For the last 8 years the compound annual growth rate for Cellectis SA's revenue is -2%. The projected CAGR for the next 3 years is 9%.

Back to Top